Literature DB >> 26684644

5th International ACC Symposium: Imaging for Diagnosis and Surveillance of Adrenal Tumors--New Advances and Reviews of Old Concepts.

Stefanie Hahner1, Elaine Caoili2, Tobias Else3.   

Abstract

Adrenocortical carcinoma (ACC) is often diagnosed incidentally. However, significant difficulties persist in diagnosing the rare ACC among the very common benign adrenal tumors, which are present in up to 5% of the population. Due to the very low prevalence of ACC, prospective studies are impossible to conduct. Two recent studies took the approach of reviewing preexisting adrenal tumors prior to the diagnosis of ACC. These data challenge current concepts of diagnosis and surveillance of incidentally discovered masses. Oncocytomas (benign and malignant) represent an entity that can be difficult to be diagnosed by radiographic characteristics and even histologically. However, some recent data provides insight into their appearance in imaging procedures. With regards to ACC specific imaging, which could be applied for differential diagnosis of adrenal tumors, surgery planning and surveillance several radionucleotides have been evaluated over the last decades showing promising results. Of particular interest, these substances can potentially be used for therapy as well.

Entities:  

Mesh:

Year:  2015        PMID: 26684644     DOI: 10.1007/s12672-015-0245-y

Source DB:  PubMed          Journal:  Horm Cancer        ISSN: 1868-8497            Impact factor:   3.869


  22 in total

1.  Characterization of adrenal masses using unenhanced CT: an analysis of the CT literature.

Authors:  G W Boland; M J Lee; G S Gazelle; E F Halpern; M M McNicholas; P R Mueller
Journal:  AJR Am J Roentgenol       Date:  1998-07       Impact factor: 3.959

2.  Incidental adrenal lesions: accuracy of characterization with contrast-enhanced washout multidetector CT--10-minute delayed imaging protocol revisited in a large patient cohort.

Authors:  Minal J Sangwaiya; Giles W L Boland; Carmel G Cronin; Michael A Blake; Elkan F Halpern; Peter F Hahn
Journal:  Radiology       Date:  2010-08       Impact factor: 11.105

3.  Radiographic Characteristics of Adrenal Masses Preceding the Diagnosis of Adrenocortical Cancer.

Authors:  T M Nogueira; R Lirov; E M Caoili; A M Lerario; B S Miller; M C B V Fragoso; N R Dunnick; G D Hammer; T Else
Journal:  Horm Cancer       Date:  2015-05-29       Impact factor: 3.869

4.  Pheochromocytomas: imaging with 2-[fluorine-18]fluoro-2-deoxy-D-glucose PET.

Authors:  B L Shulkin; N W Thompson; B Shapiro; I R Francis; J C Sisson
Journal:  Radiology       Date:  1999-07       Impact factor: 11.105

5.  Computed tomography criteria for discrimination of adrenal adenomas and adrenocortical carcinomas: analysis of the German ACC registry.

Authors:  Stephan Petersenn; Paul-Ajoy Richter; Thomas Broemel; Christian O Ritter; Timo Deutschbein; Frank-Ulrich Beil; Bruno Allolio; Martin Fassnacht
Journal:  Eur J Endocrinol       Date:  2015-01-19       Impact factor: 6.664

6.  [131I]iodometomidate for targeted radionuclide therapy of advanced adrenocortical carcinoma.

Authors:  Stefanie Hahner; Michael C Kreissl; Martin Fassnacht; Heribert Haenscheid; Pascal Knoedler; Katharina Lang; Andreas K Buck; Christoph Reiners; Bruno Allolio; Andreas Schirbel
Journal:  J Clin Endocrinol Metab       Date:  2011-12-14       Impact factor: 5.958

7.  Positron emission tomography imaging of adrenal masses: (18)F-fluorodeoxyglucose and the 11beta-hydroxylase tracer (11)C-metomidate.

Authors:  Georg Zettinig; Markus Mitterhauser; Wolfgang Wadsak; Alexander Becherer; Christian Pirich; Heinrich Vierhapper; Bruno Niederle; Robert Dudczak; Kurt Kletter
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-06-10       Impact factor: 9.236

8.  [Differential diagnosis in adrenal gland tumors using PET and 11C-metomidate].

Authors:  C Juhlin; S Törnblom; J Rastad; M Bergström; T Bonasera; A Sundin; B Långström
Journal:  Nord Med       Date:  1998-11

9.  Recommended evaluation of adrenal incidentalomas is costly, has high false-positive rates and confers a risk of fatal cancer that is similar to the risk of the adrenal lesion becoming malignant; time for a rethink?

Authors:  T J Cawood; P J Hunt; D O'Shea; D Cole; S Soule
Journal:  Eur J Endocrinol       Date:  2009-05-13       Impact factor: 6.664

10.  CT imaging characteristics of oncocytic adrenal neoplasms (OANs): comparison with adrenocortical carcinomas.

Authors:  Mansoor Khan; Elaine M Caoili; Matthew S Davenport; Ann Poznanski; Isaac R Francis; Thomas Giordano; N Reed Dunnick
Journal:  Abdom Imaging       Date:  2014-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.